Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation

Blood

Volumn 90, Issue 9, 1997, Pages 3430-3437

  Asiedu, Clement ^b   Biggs, Joseph ^b   Kraft, Andrew S ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P27;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0030783594     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3430     Document Type: Article

References (39)

1. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551, 1994
2. Hunter T: Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80:225, 1995
3. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149, 1995
4. Rovera G, Santoli D, Damsky C: Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol ester. Proc Natl Acad Sci USA 76:2779, 1979
5. Yen A, Forbes M, DeGala G, Fishbaugh J: Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment. Cancer Res 47:129, 1987
6. Mass R, Gunji H, Hirano M, Weichselbaum R, Kufe D: Phorbol ester-induced monocytic differentiation is associated with G2 delay and down-regulation of cdc25 expression. Cell Growth Differ 4:159, 1993
7. Skouv J, Jensen PO, Forchhammer J, Larsen JK, Lund LR: Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycle. Cell Growth Differ 5:329, 1994
8. Asiedu C, Biggs J, Lilly M, Kraft AS: Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res 55:3716, 1995
9. Jiang H, Lin J, Su Z-Z, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397, 1994
10. Steinman RA, Huffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389, 1994
11. Lorca T, Labbe JC, Devault A, Fesquet D, Strausfeld U, Nilsson J, Nygren PA, Uhlen M, Cavadore JC, Doree M: Cyclin A-cdc2 kinase does not trigger but delays cyclin degradation in interphase extracts of amphibian eggs. J Cell Sci 102:55, 1992
12. Gyuris J, Golemis E, Chertkov H, Brent R: Cdi1, a human G1 and S phase protein phosphatase that associates with cdk2. Cell 75:791, 1993
13. Poon RC, Hunter T: Dephosphorylation of cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science 270:90, 1995
14. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750, 1994
15. Aprelikova O, Xiong Y, Liu ET: Both p16 and p21 families of cyclin-dependent kinase (cdk) inhibitors block the phosphorylation of cyclin-dependent kinases by the cdk-activating kinase. J Biol Chem 270:18195, 1995
16. Kato J-Y, Matsuoka M, Polyak K, Massagué J, Sherr CJ: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487, 1994
17. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E: Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science 271:499, 1996
18. Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI: A novel inhibitor of cyclin-cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 14:3683, 1994
19. Kiyokawa H, Richon VM, Rifkind RA, Marks PA: Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14:7195, 1994
20. Guo K, Wang J, Andres V, Smith RC, Walsh K: MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15:3823, 1995
21. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K, Akiyama T: Constitutive overexpression of cdk2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J Biol Chem 270:23031, 1995
22. Yoshizumi M, Hsieh C-M, Zhou F, Tsai J-C, Patterson C, Perrella MA, Lee M-E: The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol 15:3266, 1995
23. Smith E, Frenkel B, Schlegel R, Giordano A, Lian JB, Stein JL, Stein GS: Expression of cell cycle regulatory factors in differentiating osteoblasts: Postproliferative up-regulation of cyclins B and E. Cancer Res 55:5019, 1995
24. Lucibello FC, Sewing A, Brusselbach S, Burger C, Muller R: Deregulation of cycling D1 and E and suppression of cdk2 and ckd4 in senescent human fibroblasts. J Cell Sci 105:123, 1993
25. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massagué J: Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta. Science 260:536, 1993
26. Fisher RP, Morgan DO: A novel cyclin associates with MO15/cdk7 to form the cdk-activating kinase. Cell 78:713, 1994
27. Darbon J-M, Devault A, Taviaux S, Fesquet D, Martinez A-N, Galas S, Cavadore J-C, Doree M, Blanchard J-M: Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. Oncogene 9:3127, 1994
28. Gu Y, Rosenblatt J, Morgan DO: Cell cycle regulation of cdk2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J 11:3995, 1992
29. Tassan J-P, Schutz SJ, Bartek J, Nigg EA: Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (cdk-activating kinase). J Cell Biol 127:467, 1994
30. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668, 1995
31. Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A: Formation of p27-cdk complexes during the human mitotic cell cycle. Cell Growth Differ 7:135, 1996
32. 1 growth arrest of murine B-cell lymphomas. Mol Biol Cell 7:553, 1996
33. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Sal GD, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682, 1995
34. WAFI/CIPI/SDI in differentiating human leukemic cells. J Clin Invest 95:973, 1995
35. Polyak K, Kato J, Solomon MJ, Sherr CJ, Massagué J, Roberts JM, Koff A: p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9, 1994
36. Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861, 1996
37. Seimiya H, Tsuruo T: Differential expression of protein tyrosine phosphatase genes during phorbol ester-induced differentiation of human leukemia U937 cells. Cell Growth Differ 4:1033, 1993
38. Hall M, Bates S, Peters G: Evidence for different modes of action cyclin dependent inhibitors: p15 and p16 binding, p21 and p27 bind to cyclins. Oncogene 11:1581, 1995
39. Poon RY, Toyoshima H, Hunter T: Redistribution of the CDK inhibitor p27 between different cyclin CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 6:1197, 1995